SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-15-009664
Filing Date
2015-11-05
Accepted
2015-11-05 16:16:44
Documents
11
Period of Report
2015-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q dvax-10q_20150930.htm 10-Q 1678921
2 EX-31.1 dvax-ex311_140.htm EX-31.1 18078
3 EX-31.2 dvax-ex312_141.htm EX-31.2 18009
4 EX-32.1 dvax-ex321_142.htm EX-32.1 6211
5 EX-32.2 dvax-ex322_143.htm EX-32.2 6268
  Complete submission text file 0001564590-15-009664.txt   6057828

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT dvax-20150930.xml EX-101.INS 1298993
7 XBRL TAXONOMY EXTENSION SCHEMA dvax-20150930.xsd EX-101.SCH 37283
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE dvax-20150930_cal.xml EX-101.CAL 47732
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE dvax-20150930_def.xml EX-101.DEF 158253
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE dvax-20150930_lab.xml EX-101.LAB 345928
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE dvax-20150930_pre.xml EX-101.PRE 258674
Mailing Address 2929 SEVENTH STREET SUITE 100 BERKELEY CA 94710
Business Address 2929 SEVENTH STREET SUITE 100 BERKELEY CA 94710 5108485100
DYNAVAX TECHNOLOGIES CORP (Filer) CIK: 0001029142 (see all company filings)

IRS No.: 330728374 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-34207 | Film No.: 151200860
SIC: 2834 Pharmaceutical Preparations